ArticlePopulation health metrics2025
Development of novel DALY-based indices for assessing productivity loss and resource allocation for liver cancer in the MENA region.
Article in Population health metrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo develop new DALY-based indices for measuring productivity loss, health system resilience, and resource allocation efficiency for liver cancer across eight MENA countries. These will be combined into the Integrated Health-Adjusted Productivity Index (IHAPI) to aid health policy development.
settingThe final analysis utilized 289,067 data entries from a total of 394,944, including information from Egypt, Iran, Jordan, Kuwait, Turkey, Saudi Arabia, Oman, and the UAE from 2000 to 2021.
designThis study adopted a cross-country approach, employing secondary data to develop six composite measures: the Health-Adjusted Productivity Loss Index (HAPLI), the Economic Vulnerability to Health Impact Index (EVHI), the Relative Resilience to Liver Cancer Loss Index (RLCL), the Resource Allocation Efficiency Index (RAEI), the Health System Response Index (HSRI), and the Sustainable Development Health Equity Index (SD-HEI). These measures were aggregated into the IHAPI score.
resultsThe analysis revealed that the most significant factor influencing the IHAPI score was the EVHI (feature importance = 0.73). Egypt exhibited the highest growth in Disability-Adjusted Life Years (DALY), leading to substantial productivity loss (HAPLI), while Saudi Arabia and Jordan demonstrated greater resilience (as indicated by higher RLCL scores and less variability in the IHAPI). The UAE and Turkey reported strong HSRI and Productivity Performance Index (PPI) rates, suggesting better-coordinated preventive investments. Conversely, the highest variability in the indices was observed in Iran and Oman, particularly in the SD-HEI and Total Productivity Loss and Inequality Index (TPLTI), indicating unstable equity and trends. Kuwait exhibited moderate performance in burden and resource allocation indices.
conclusionThis paper presents an integrative model for evaluating both economic and health system impacts of liver cancer in MENA countries. The IHAPI and its related indices provide valuable insights that can be implemented to enhance equity, efficiency, and resilience in health policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.